Literature DB >> 9710221

Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoire.

R Obst1, C Münz, S Stevanović, H G Rammensee.   

Abstract

BALB/c-derived spleen cells were depleted of cytotoxic T lymphocytes (CTL) recognizing allogeneic (H2b) and TAP-negative cells followed by stimulation with the same cells loaded with a synthetic library binding to H2-Kb. The resulting CTL lines were found to differ widely in peptide specificity and to exhibit an avidity towards the library as that demonstrated for syngeneic CTL. These results demonstrate that positive selection in the context of a certain MHC molecule does not seem to be required for generating high-avidity TCR that are restricted by the same molecule. However, positive selection increases the frequency of such CTL. By raising T cell lines from a repertoire which did not undergo negative selection by the restriction element in question, it becomes possible to produce effective self-peptide/ MHC as well as nonself-peptide/MHC-specific CTL as tools for adoptive tumor immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9710221     DOI: 10.1002/(SICI)1521-4141(199808)28:08<2432::AID-IMMU2432>3.0.CO;2-0

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Structural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restriction.

Authors:  Amy A Simpson; Fiyaz Mohammed; Mahboob Salim; Amy Tranter; Alan B Rickinson; Hans J Stauss; Paul A H Moss; Neil M Steven; Benjamin E Willcox
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  On the role of thymic epithelium vs. bone marrow-derived cells in repertoire selection of T cells.

Authors:  R M Zinkernagel; A Althage
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

3.  A similarity in peptide cross-reactivity between alloantigen- and nominal antigen-induced CD8+ T cell responses in vitro.

Authors:  Qian Yu; Li Zhang; Lichen Ouyang; Yeli Gong; Zhihui Liang; Guanxin Shen; Xiufang Weng; Xiongwen Wu
Journal:  Immunogenetics       Date:  2012-12-12       Impact factor: 2.846

4.  Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells.

Authors:  J Joseph Melenhorst; Phillip Scheinberg; Ann Williams; David R Ambrozak; Keyvan Keyvanfar; Melody Smith; J Philip McCoy; Nancy F Hensel; Daniel C Douek; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-06       Impact factor: 5.742

5.  High-frequency alloreactive T cells augment effector function of low-frequency CD8+ T-cell responses under CD28/CD154 blockade.

Authors:  Tamara L Floyd; Steven B Orr; Shana M Coley; Samantha S Hanna; Maylene E Wagener; Allan D Kirk; Christian P Larsen; Mandy L Ford
Journal:  Transplantation       Date:  2010-05-27       Impact factor: 4.939

Review 6.  Allo-reactive T cells for the treatment of hematological malignancies.

Authors:  J H F Falkenburg; I Jedema
Journal:  Mol Oncol       Date:  2015-10-24       Impact factor: 6.603

7.  The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.

Authors:  R Obst; N Netuschil; K Klopfer; S Stevanović; H G Rammensee
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

8.  MHC multimer-guided and cell culture-independent isolation of functional T cell receptors from single cells facilitates TCR identification for immunotherapy.

Authors:  Georg Dössinger; Mario Bunse; Jeannette Bet; Julia Albrecht; Paulina J Paszkiewicz; Bianca Weißbrich; Isabell Schiedewitz; Lynette Henkel; Matthias Schiemann; Michael Neuenhahn; Wolfgang Uckert; Dirk H Busch
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.